SEC Form 4 · accession 0000921895-16-005080

Actinium Pharmaceuticals, Inc. · ATNM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Jun 30, 2016

Accepted (ET)

Jul 5, 2016 · 4:36 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001388320

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 30, 2016	S	15,200	$1.80	D	5,140,786	D
Common Stock	Jun 30, 2016	S	300	$1.8025	D	5,140,486	D
Common Stock	Jun 30, 2016	S	300	$1.805	D	5,140,186	D
Common Stock	Jun 30, 2016	S	3,350	$1.82	D	5,136,836	D
Common Stock	Jul 1, 2016	S	44,841	$1.80	D	5,091,995	D
Common Stock	Jul 1, 2016	S	3,200	$1.8001	D	5,088,795	D
Common Stock	Jul 1, 2016	S	200	$1.8015	D	5,088,595	D
Common Stock	Jul 1, 2016	S	100	$1.8025	D	5,088,495	D
Common Stock	Jul 1, 2016	S	11,350	$1.805	D	5,077,145	D
Common Stock	Jul 1, 2016	S	25,800	$1.81	D	5,051,345	D
Common Stock	Jul 1, 2016	S	7,362	$1.8101	D	5,043,983	D
Common Stock	Jul 1, 2016	S	200	$1.8115	D	5,043,793	D
Common Stock	Jul 1, 2016	S	4,300	$1.815	D	5,039,483	D
Common Stock	Jul 1, 2016	S	13,830	$1.82	D	5,025,653	D
Common Stock	Jul 1, 2016	S	1,400	$1.825	D	5,024,253	D
Common Stock	Jul 1, 2016	S	700	$1.83	D	5,023,553	D
Common Stock	Jul 1, 2016	S	3,617	$1.85	D	5,019,936	D
Common Stock	Jul 1, 2016	S	100	$1.855	D	5,019,836	D
Common Stock	Jul 1, 2016	S	5,900	$1.86	D	5,013,936	D
Common Stock	Jul 1, 2016	S	1,400	$1.865	D	5,012,536	D
Common Stock	Jul 1, 2016	S	1,700	$1.87	D	5,010,836	D
Common Stock	Jul 1, 2016	S	2,550	$1.88	D	5,008,286	D
Common Stock	Jul 1, 2016	S	100	$1.90	D	5,008,186	D
Common Stock	Jul 1, 2016	S	300	$1.91	D	5,007,886	D

No Table II lines on this filing.